Vaccine divide between wealthier and less developed countries grows larger

A health worker carries vaccines over a road that was blocked by a landslide in the Himalayan state of Himachal Pradesh in India. Credit: Adnan Abidi/Reuters
A health worker carries vaccines over a road that was blocked by a landslide in the Himalayan state of Himachal Pradesh in India. Credit: Adnan Abidi/Reuters

Nearly 10 months after the first Covid-19 vaccine became available to the public, the divide between nations that have shots and those that don’t is starker than ever. The U.S. and other rich countries such as Israel and the U.K. are doling out third shots, while in low-income countries—the vast majority of which are in Africa—just 2.2% of people have received even a single dose.

The reason is principally a lack of supply from an international vaccination program that has struggled to secure enough shots, exacerbated in some places by inadequate infrastructure, hesitancy and armed conflict.

In the countries that lack immunizations, the pandemic continues to wreak havoc on lives and livelihoods, in some places setting back the economic and social gains of a generation. Uninterrupted transmission in those places could also allow the virus to mutate into variants that are resistant to existing vaccines.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

The WHO’s Africa director, Matshidiso Moeti, said [September 23] that monthly vaccine shipments to Africa will have to rise more than sevenfold, from around 20 million doses to 150 million doses a month, if the continent is to immunize 70% of its population by next September. 

This is an excerpt. Read the original post here.

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-09-16-at-2.26.42-PM
Viewpoint: How to ecologically damage America’s forests: Ban glyphosate
Screenshot-2026-09-20-at-9.03.54-AM
From Malaysia to the world: A pioneering science communicator reimagines global science communication for a digital age
ChatGPT-Image-Sep-17-2026-12_28_43-PM
Vitamin D, omega-3 fish oil and glucosamine supplements could cause brain damage 
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-09-20-at-4.31.28-PM
White House drafting executive order to control what OMB Director Vought claims are “woke” NIH science grants
ChatGPT-Image-Sep-20-2026-04_22_32-PM
What’s Trump’s ‘AI Force’? Administration rushes to announce ill-defined watchdog agency and czar amid criticism of its resistance to curb AI acceleration
Screenshot-2026-08-12-at-11.31.46-AM
AI is helping develop new vaccines
Screenshot-2026-09-14-at-4.31.14-PM
Viewpoint: What’s the likely impact when the EPA loosens rules limiting methane pollution from oil and gas wells?
Screenshot-2026-08-19-at-6.19.42-PM
Facts & Fallacies podcast: 'Regenerative farming'? RFK Jr.’s federal push romanticizes the past and risks food security
ChatGPT-Image-Sep-18-2026-10_49_24-AM
‘Symptom borrowing’: Young people are copying health problems they see on TikTok
ChatGPT-Image-Aug-28-2026-03_33_46-PM
Viewpoint: Bad science—Five bogus Trump administration claims about vaccines and autism
ChatGPT-Image-Sep-11-2026-01_53_42-PM
Should doctors engage in social media to counter misinformation?
ChatGPT-Image-Sep-9-2026-02_48_24-PM
Viewpoint: Trump-RFK Jr. report on “Gender Ideology & Left-wing Ideology’ targets LGBTQ community—and science
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.